A detailed history of Franklin Resources Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,383 shares of MDGL stock, worth $433,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,383
Previous 1,383 -0.0%
Holding current value
$433,031
Previous $293,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$212.22 - $292.96 $21,858 - $30,174
103 Added 8.05%
1,383 $293,000
Q2 2024

Aug 14, 2024

SELL
$193.33 - $291.99 $25,906 - $39,126
-134 Reduced 9.48%
1,280 $358,000
Q1 2024

May 13, 2024

BUY
$171.37 - $283.23 $242,317 - $400,487
1,414 New
1,414 $377,000
Q2 2023

Aug 11, 2023

BUY
$203.88 - $312.0 $427,332 - $653,952
2,096 Added 236.04%
2,984 $689,000
Q1 2023

May 12, 2023

BUY
$231.06 - $307.08 $26,340 - $35,007
114 Added 14.73%
888 $215,000
Q4 2022

Feb 10, 2023

BUY
$58.39 - $296.54 $45,193 - $229,521
774 New
774 $224,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.36B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.